skeletal muscle biopsies; spinal cord
iPSC-derived motor neurons
genetically engineered animal model
not specified
RNA-seq; RNase R Treatment; RT-qPCR; divergent primers PCR; Clinical Sample Validation; Bioinformatics Analysis
reduced in ALS muscle, spinal cord, and C9-ALS motor neurons; linear counterpart FGGY mRNA increases in muscle
hsa_circ_0006633 is downregulated in ALS skeletal muscle while its linear counterpart FGGY mRNA is increased; it is also reduced in ALS spinal cord and in C9-ALS iPSC-derived motor neurons. No mechanism was established.
0.585
Transcriptomic analysis of human ALS skeletal muscle reveals a disease-specific pattern of dysregulated circRNAs.
combined biological and clinical study